Tag Archives: Northwell Health

Long Island, New York to Become Epicenter for Cell and Gene Therapy Innovation

Plans for a $430 million New York BioGenesis Park, a Cell and Gene Therapy Innovation Hub, in Lake Success, Long Island, were unveiled by NYS Governor Kathy Hochul. The state is providing $150 million in funding, the largest state grant for CGT in the nation © Karen Rubin/news-photos-features.com

By Karen Rubin, News-Photos-Features.com, [email protected]

Long Island will soon become the epicenter for some of the most important medical breakthroughs in the world, with the opening of New York BioGenesis Park, a Cell and Gene Therapy Innovation Hub.

New York Governor Kathy Hochul  unveiled the plans for the state-of-the-art facility,  to be developed by The Albanese Organization, Inc., to catalyze CGT research, development, clinical manufacturing, and commercialization across New York State. With a historic $150 million state investment—the largest nationwide for a cell and gene therapy hub—NYBGP would accelerate the delivery of new therapies from lab to patient in New York’s diverse communities. This transformative hub aims to establish New York as the leading global destination for CGT innovation, driving economic growth, attracting top talent, and revolutionizing patient care statewide and beyond.

NYS Governor Kathy Hochul describes plans for a $430 million New York BioGenesis Park, a Cell and Gene Therapy Innovation Hub, in Lake Success, Long Island © Karen Rubin/news-photos-features.com
 

“With this groundbreaking hub, New York has the opportunity to stake its claim as the epicenter of cell and gene therapy innovation,”Governor Hochul said. “We’re not just advancing medical science; we’re creating a powerhouse that will drive our economy, generate thousands of high-skilled jobs, and bring hope to millions facing life-threatening diseases. This investment reaffirms our commitment to leading the future of healthcare and ensuring that the next medical breakthrough happens right here in New York.”

Cell and gene therapies are revolutionary treatments that modify a patient’s cells or genes to combat diseases at their source. Offering hope for previously incurable conditions—including cancers, genetic disorders, and autoimmune diseases—these approaches target illnesses at the cellular and genetic levels. They have the potential to provide more effective, longer-lasting treatments with fewer side effects than traditional methods. Advancements in these therapies could revolutionize healthcare, paving the way for personalized medicine and new possibilities for patients who have exhausted other treatment options.

“For people in the business, the healthcare professions of treating those who have complex diseases, this is an extraordinary opportunity,” Governor Hochul said. “And, cell and gene therapy, CGT, is one of the fastest growing treatment tools in the toolkit we have to deal with many, many diseases, and it’s near unlimited potential when it comes to changing outcomes for people diagnosed with cancer and rare diseases.”

With CGT, she said, cells are grown outside the body, genes are modified to eradicate harmful mutations, and then they’re fine-tuned by specialists in a lab, introduced into the patient where they go directly to work attacking cancerous cells and replacing faulty genes.

“It’s extraordinary when you think about that. Extraordinary. And, doctors call these therapies, not just miraculous, but a true paradigm shift. And their application is absolutely limitless. And, we think about the diseases that we’re trying to tackle. Those that have affected our own family members.”

Diseases that are considered incurable today: Parkinson’s, ALS, Multiple Sclerosis, heart disease, cancer, could be prevented, diagnosed, treated and cured using these technologies.

New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization © Karen Rubin/news-photos-features.com

New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization. At full build-out, the 700,000-square-foot park would create an end-to-end Cell and Gene Therapy innovation and supply center, featuring interconnected areas for public engagement, research, manufacturing, and collaboration. The project would be developed in multiple phases, with Phase One comprising a 331,000-square-foot facility on Northwell Health’s campus in Lake Success, including the first Cell and Gene Therapy Tower and Contract Development and Manufacturing Organizations (CDMO) Tower. Phase One is already poised to advance, with conditional commitments from two anchor tenants; one would operate the CDMO, the other would operate the incubator.

A cornerstone of New York BioGenesis Park is its incubator, supported by a $50 million investment from ESD’s Long Island Investment Fund. This facility will empower early-stage therapeutic developers by offering state-of-the-art wet lab space, shared equipment, office space, and other essential resources. This nurturing environment would provide Cell and Gene Therapy companies with access to specialized equipment, mentoring, and stage-appropriate financial guidance. As a critical component of New York BioGenesis Park, the incubator is poised to catalyze the growth of promising Cell and Gene Therapy companies by providing them with resources and support, unlocking their potential for innovation and success.

This initial phase is expected to create approximately 830 full time union construction jobs and a combined estimate of 700 jobs related to Cell and Gene Therapy development and provision of services and technologies required by Cell and Gene Therapy developers, such as Contract Development and Manufacturing Organizations, vector developers, and advanced diagnostic providers, as well as staff required for operation of the Center. Phase Two would further expand lab and office space, enhancing the park’s capabilities for Cell and Gene Therapy companies and service providers.

Governor Hochul said that she expected the zoning and environmental studies to be completed by 2026 and the first phase – a 7,000 sq. ft. facility of what will ultimately be 330,000 sq. ft. to support research, development, education, and commercialization – to open by 2029. In the meantime, researchers are already at work in existing labs.

“New York BioGenesis Park represents a transformative investment in Long Island’s future and New York State’s position as a global leader in biotechnology advancements,” Empire State Development Board Chairman Kevin Law said. “This project not only promises to create hundreds of high-skilled jobs but also establishes a world-class ecosystem for cell and gene therapy innovation. By leveraging Long Island’s exceptional talent pool and research institutions, we’re laying the foundation for breakthroughs that will save lives and drive economic growth for decades to come.”

The state, through its Empire State Development office, is providing $150 million of the $430 million development cost, which will support 830 construction jobs and 700 full-time jobs – “as close as it gets to a sure bet,” Hochul said because CGT that this global market is going to go from $8.5 billion a year to over $21 billion a year, and projected to be worth over $120 billion in a few years.

NYS Governor Kathy Hochul describes plans for a $430 million New York BioGenesis Park, a Cell and Gene Therapy Innovation Hub, in Lake Success, Long Island © Karen Rubin/news-photos-features.com

“We’ll be at the forefront of this movement with these investments today. So, I want to make sure that we know that Long Island, again, is at the forefront of this. This is a new, whole new market, a whole new opportunity for us and thousands of jobs being constructed here and beyond.”

Governor Hochul had designated Long Island as a hub for life sciences and technology innovation, climate and renewable energy. She noted that Long Island has the nation’s largest offshore wind facility that is commercial utility grade “and we’re just getting warmed up.” The state has designated Stony Brook University as one of two flagships.

All of this contributes to the sense of Long Island’s “exceptionalism, that there’s nothing holding us back because we have everything. We have the smartest people, the most incredible academic institutions. We have research.

“You think about what’s happening all over, every corner of this island. It is the place that people want to be who are inventing the future. And the future of healthcare is so much brighter now. The doctors, and researchers and the therapists who are coming here. And they’ll be building their lives here on Long Island. Now we need to build them some homes, but that’s another topic, okay? Let’s give them a place to live.

“And, we’re making progress there, and I want to continue to make this one of the most desirable places to live in all of New York, because it truly is. And having all these academic institutions and people coming here, young people coming here for an education, an opportunity to work in this innovative field, will then say, ‘I don’t have to go back to the home state I came from. I can stay right here and build a beautiful life’.”

“But what this technology gives, more than anything else, is hope to people whose lives are changed overnight with a diagnosis.

“You don’t have to be relegated to the same outcome you would have, but for these investments, but for this technology, but for this innovation. And, so, I do believe that New York state will become America’s premier CGT innovator, and I’m counting on it happening right here.”

“My friends, all of you who are involved with this, I honor you. This is one of the most impactful things we’ll do. In our time in these positions in elective office, and to all those in the medical profession who truly believe in this and the ones who are coming up with innovations and taking more time off the clock to get these products to market, to get them into people and help save their lives.

New York BioGenesis Park is envisioned as a cutting-edge, full-service campus dedicated to advancing cell and gene therapies and accelerating their commercialization and designed to foster collaboration among scientists, researchers and institutions © Karen Rubin/news-photos-features.com
 

“So, we can’t control everything, but an opportunity here today to free people from a life of pain, uncertainty, and even death — that’s why we’re here today. That moral obligation we have to leave this place better than we found it. After today, we can say we accomplished this. We are leaving this place better than we found it.

“Healing the sick, giving people hope who are hopeless. That’s as good as it gets, my friend. Thank you for being part of this extraordinary story. Thank you everyone who’s involved in this.”

New York BioGenesis Park would foster strong ties with academic and medical institutions throughout New York, creating a robust ecosystem for Cell and Gene Therapy innovation. Collaborating with the Empire State Cellular Therapy Consortium and world-class institutions like Cold Spring Harbor Laboratory, the Feinstein Institutes, Northwell Health, Roswell Park, Stony Brook University, Weill Cornell, Columbia University and others around the state. New York BioGenesis Park would enhance research synergies and accelerate medical breakthroughs. This ecosystem would bring together experts in advanced Cell and Gene Therapy therapies, offering specialized facilities, services, and resources to both tenants and collaborating institutions. By facilitating cutting-edge science, innovative technology development and novel approaches to clinical trials, New York BioGenesis Park would ensure New York’s institutions remain globally competitive in groundbreaking Cell and Gene Therapy research and commercialization.

The New York BioGenesis Park and the Cell and Gene Therapy manufacturing expansion at Roswell Park would create a powerful, interconnected network that leverages complementary resources and capabilities at both ends of the state. By fostering a comprehensive ecosystem that spans from basic research to clinical application and commercialization, New York is positioning itself as the nation’s leading destination for Cell and Gene Therapy research, development, and manufacturing.

Northwell Health President and CEO Michael J. Dowling said, “We are committed to supporting New York State in establishing this innovative cell and gene therapy hub on Long Island. The facility will be a game changer for physician-scientists, researchers and innovative companies, some of which are already working together in the region to advance novel biomedical treatments in the fight against cancer and other devastating diseases, offering new hope for our diverse communities across the state.

Northwell Health President and CEO Michael J. Dowling: “This is an investment in life-saving technology. We will be doing things never done before, expand on what we think we can do, It’s also about prevention, not just treatment, and recovery.” © Karen Rubin/news-photos-features.com

“This is an investment in life-saving technology. We will be doing things never done before, expand on what we think we can do, It’s also about prevention, not just treatment, and recovery. This is an investment in collaboration and partnerships, working across all research areas, the best minds, researchers, intellectuals, to work together to create a new future,”  Dowling said. “Imagine what could happen. This is a legacy event.”

The setting of the new campus is ideal – in close proximity to two other Northwell campuses and the largest ambulatory cancer center in the region.

The Albanese Organization, Inc., a Long Island-based developer with more than 70 years of experience in managing public-private partnerships, was selected following a Request for Proposals issued in December 2023 to lead the comprehensive process to design, finance, build, market, tenant, and operate the Long Island Cell and Gene Therapy Center. “This selection ensures that the project will be executed from conception to operation with an experienced development team, leveraging Albanese’s extensive expertise in developing large life science innovation campuses,”  the state said.

 “The Albanese Organization and our development team are honored and excited to be designated by Empire State Development to enter into this public private partnership that will realize the Governor’s vision to create a ‘Hub of the Future’ for Cell and Gene Therapy in Lake Success, Long Island. This transformative development will serve as a significant catalyst for advancing cell therapy research, development, clinical manufacturing, and commercialization across the State that will lead to increased access to transformative, life-saving treatments. The Hub will also further amplify and expand the economic engine that is the life sciences industry within New York State, and specifically Long Island.”

 “The New York BioGenesis Park represents a transformative investment in Long Island’s future and solidifies our region’s position at the forefront of biotechnology innovation,” stated Long Island Regional Economic Development Commission Co-Chairs Linda Armyn and Dr. Kimberly R. Cline said.”This visionary project not only promises to create high-quality jobs and drive economic growth, but it also establishes Long Island as a global hub for cell and gene therapy research and development. By leveraging our region’s world-class academic institutions, skilled workforce, and entrepreneurial spirit, New York BioGenesis Park will catalyze breakthroughs that will save lives and shape the future of healthcare.”

NYS Assemblywoman Gina Sillitti, who helped win the funding, said, “New York State’s $150 million investment in a gene therapy research hub at Lake Success is a transformative step in developing Long Island’s biotechnology sector”. © Karen Rubin/news-photos-features.com
 

State Assemblywoman Gina Sillitti, who helped win the funding, said, “New York State’s $150 million investment in a gene therapy research hub at Lake Success is a transformative step in developing Long Island’s biotechnology sector. I thank Governor Hochul for championing this initiative, which will create hundreds of jobs and further solidify Long Island’s place as a national leader in cutting-edge medical research and treatments.”

“New York is already a leader in the science of making ‘living cures’ from our own cells,” Roswell Park Comprehensive Cancer Center President and CEO Candace S. Johnson, PhD said. “With these historic investments in the Roswell Park GMP Engineering & Cell Manufacturing Facility and New York BioGenesis Park, Governor Kathy Hochul and Empire State Development are making sure our teams are supported by an innovation infrastructure powerful enough to transform their curiosity into cures”

New York Blood Center Enterprises President and CEO Christopher D. Hillyer, MD said,“The creation of the Long Island Center for Cell and Gene Therapy represents a critical investment in the future of medicine. New York Blood Center Enterprises and Comprehensive Cell Solutions are extremely proud to be part of the team that will position New York as a global leader in life sciences, particularly in cell and gene therapy, offering new hope to patients facing diseases once thought untreatable.”

NYS Governor Kathy Hochul with Dr. Ayanna Bryan, a Senior Program Director at New York Blood Center; Empire State Development President, CEO, and Commissioner Hope Knight; Northwell Health President and CEO Michael J. Dowling; NYS Assemblywoman Gina Sillitti and Kevin Law, the Chair of Empire State Development © Karen Rubin/news-photos-features.com

Cold Spring Harbor Laboratory President and CEO Bruce Stillman, PhD said, “The New York State cell and gene therapy initiative on Long Island will be a most welcome addition to the region’s biomedical research enterprise, and Cold Spring Harbor Laboratory looks forward to partnering with the CGT initiative. We thank Governor Hochul and Empire State Development for pioneering this exciting research expansion.”

The Long Island Cell and Gene Therapy Innovation Hub stands to serve as a cornerstone of New York’s $620 million Life Science Initiative. Aimed at establishing the state as a national leader in the broader life sciences industry—including biotechnology, pharmaceuticals, and medical technology—the initiative allocates $320 million for strategic programs to attract new technologies, promote investment in emerging fields, and stimulate life science business growth and employment statewide. This multifaceted approach seeks to spur the development of a world-class research cluster, enhance the state’s ability to commercialize groundbreaking research, and drive economic growth.

By solidifying New York’s position in life sciences innovation, the initiative advances Cell and Gene Therapy development and strengthens the state’s global competitiveness. Read New York State’s Life Science Initiative Strategic Plan here.

 __________________________             

© 2024 News & Photo Features Syndicate, a division of Workstyles, Inc. All rights reserved. For editorial feature and photo information, go to www.news-photos-features.com, email [email protected]. Blogging at www.dailykos.com/blogs/NewsPhotosFeatures. ‘Like’ us at facebook.com/NewsPhotoFeatures, Tweet @KarenBRubin Threads: @news_and_photo_features

NYS Makes Significant Investment in Feinstein Institutes to Make Long Island a Life Sciences Global Leader 

New York State Governor Kathy Hochul at Northwell Health on Long Island announces new funding for the Feinstein Institutes for Medical Research’s Center for Bioelectronic Medicine and funding to expand life sciences on Long Island, including a $50 million competition to incentivize commercialization of new discoveries © Karen Rubin/news-photos-features.com

By Karen Rubin, News-Photos-Features.com

New York State Governor Kathy Hochul today announced the $350 million Long Island Investment Fund awarded its first grant to the The Feinstein Institutes for Medical Research to construct 40,000 square feet of new state-of-the-art labs to support medical and infectious disease research. The $10 million Long Island Investment Fund grant complements an additional $30 million in State support previously awarded to the Feinstein Institutes to modernize 20,000 square feet of its Institute of Bioelectronic Medicine, which Governor Hochul opened today. New York State’s assistance is part of an $85 million modernization effort at the Feinstein Institutes for Medical Research in Manhasset, Nassau County, and a broader initiative to highlight the growing life science industry on Long Island. The Feinstein Institutes is the research arm of Northwell Health and is one of the leading laboratory and research centers in the country, conducting cutting-edge studies that seek to cure diseases.

“New York is leading the way in medical innovation, and the Long Island Investment Fund will support life-saving research on the cutting edge of the life sciences industry,” Governor Hochul said.”Our investment in the Institute of Bioelectronic Medicine is already improving the lives of everyday New Yorkers, and the additional Long Island Investment Fund award announced today reaffirms our commitment to remaining a national leader in the health and medical research fields. I am proud to support the Feinstein Institutes and their research, which will lead to life-changing medicine and treatments that will improve the lives of New Yorkers on Long Island and across the State.”

The field of bioelectronic medicine was born here, she said, thanks to the pioneering work of Dr. Kevin J. Tracey, President and CEO of Feinstein Institutes, and the funding will enable this work to be greatly expanded, attracting top scientists from around the world.

Included as part of Governor Hochul’s FY 2023 Enacted Budget, the Long Island Investment Fund focuses on projects that will support and grow the regional economy, enhance communities, and have lasting economic impacts across Long Island. The Fund’s $10 million award to the Feinstein Institutes for Medical Research will support the renovation and construction of 26 new state-of-the-art research labs on two floors as well as the hiring of 10 new principal investigators and 60 research employees. These modernized labs will advance research efforts to develop novel therapies for cancer, diabetes, obesity, lupus, and other conditions.

Long Island has become a life sciences hub, with a defined corridor that links Stony Brook University, Brookhaven National Labs (energy), Cold Spring Harbor Laboratory (genomics) and Northwell’s Feinstein Institutes.

The state is also launching a $50 million life science business competition on Long Island, in order to bridge the divide between research and commercialization, and bring the innovations to market with start-ups, many of which may well come out of the four research institutions.

In all, New York is investing $620 million in life sciences sector, statewide.

New York State Governor Kathy Hochul with Empire State Development’s President, CEO and Commissioner Hope Knight and Chairman Kevin Law, announce the $350 million Long Island Investment Fund, which will focus largely on developing life sciences research and businesses © Karen Rubin/news-photos-features.com

“The Long Island Investment Fund represents a strategic investment to further enhance the region as a powerhouse for the life sciences industry, which is an important driver of New York State’s economy,” Empire State Development President, CEO and Commissioner Hope Knight said. “The Feinstein Institutes play a critical role in life-changing medical discoveries and therapeutics that can improve our everyday lives. ESD is proud to support the growth of visionary life sciences companies like the Feinstein Institutes, whose work is crucial to building a healthier and stronger Empire State.”

The Feinstein Institutes is the global scientific home of bioelectronic medicine, a growing scientific field that uses technology to read and modulate electrical activity within the body’s nervous system. The new, modernized labs at the Institute of Bioelectronic Medicine will support discoveries to find cures that will reduce the need for drugs, reduce painful side effects, and give life back to people who are suffering. Early discoveries have emerged from its labs, opening new treatment options for patients with diseases such as rheumatoid arthritis, diabetes, paralysis, and even cancer. Clinical studies in bioelectronic medicine have already yielded results with those who are paralyzed: recent research utilizing an over-the-skin spinal cord stimulation patch has allowed participants to regain their ability to move and feel. 

Governor Hochul acknowledged that the new technology could also help in the state’s effort to diagnose and treat Long COVID which is afflicting so many New Yorkers.

The Institute of Bioelectronic Medicine’s renovation includes wet-lab bench space, multiple tissue culture rooms, cold storage rooms, workstations for researchers, and a brand-new Biosafety Level 3 facility to allow new research into infectious diseases and other complex viruses, such as COVID-19. The expansion also supports the hiring of 13 new principal investigators and 100 new research employees.

Dr. Kevin J. Tracey, President and CEO of Feinstein Institutes, in one of the new labs devoted to making breakthroughs in bioelectronic medicine. The facilities are expected to attract world-class researchers © Karen Rubin/news-photos-features.com

The Feinstein Institutes President and CEO Dr. Kevin Tracey said, “At the Feinstein Institutes, scientific progress is made every day. With the proper facilities and tools, we can help advance that progress even further. We are thankful to the Governor and Empire State Development for their funding of our new space, and we look forward to continuing our breakthrough medical research that will benefit our Long Island communities and beyond.”

Northwell Health’s President and CEO, Michael Dowling said,”This new facility and its resources, made possible by Governor Hochul and the Empire State Development, will allow our researchers at The Feinstein Institutes – Northwell’s home of research and the global scientific home of bioelectronic medicine – to pursue their mission of discovering new treatments to cure disease and improve the health of the communities we serve.”

Long Island is at the forefront of the life sciences industry as new research and discoveries in bioelectronic medicine – a new scientific field born and bred on Long Island – will attract the best and brightest researchers and world-leading strategic partners to create the cures that can transform lives. The life sciences industry has become a powerful engine of economic growth and innovation for New York, turning key regions of the State into dynamic life science hubs. Investing in life sciences is crucial to identify the next scientific or medical breakthrough that will develop new life-saving technologies. Through its support of the Feinstein Institutes’ growth, New York is expanding its ability to commercialize research and spur the growth of a world-class life science industry on Long Island and across the State.

“Under Governor Hochul’s leadership, New York is making smart investments to catalyze economic growth on Long Island. The Long Island Investment Fund will help the region thrive and strengthen New York’s leadership in the global innovation economy,” Empire State Development Board Chairman Kevin Law said. “The Fund’s $10 million award to the Feinstein Institutes reaffirms our commitment to the growing life sciences ecosystem that will support the advancement of game-changing medical discoveries.”

“Thanks to smart investments by the State of New York in partnership with the private sector, Long Island’s life sciences industry is growing and thriving, bringing great jobs to our community, and driving innovation that will make our world a better place,” State Senator Anna M. Kaplan said. “I fought for the Long Island Investment Fund to be included in this year’s state budget because we need to continue making smart investments in our community that build on our many strengths and make our region more attractive for private investors and job creators to set up shop and expand their operations locally. I’m thrilled that, thanks to this fund, the world-class Feinstein Institute for Medical Research right here in Manhasset will be able to modernize their Institute of Bioelectronic Medicine that’s doing incredible work to cure diseases and change the world.”

Dr. Kevin J. Tracey President and CEO of Feinstein Institutes discusses the breakthrough science of bioelectronic medicine © Karen Rubin/news-photos-features.com

During a walk-through of the new and renovated labs, Dr. Tracey explained how bioelectric medicine involves building devices to control nerves, to treat disease. “Pick a disease, pick target, figure out the  neural signals to control target.” The technology can be used to activate immune system to intercept a disease. “Send the right neural signal to the right nerve to trigger immune system.” It can be used to create new neural pathways to restore function to stroke victims, and has application to rehabilitation, such as the loss of hand function after a car accident.

But, he adds, you can’t treat a disease until you understand its mechanism, which is why mental illness is not on the list at this time.

“Things are happening fast,” he said, The FDA granted the technology “breakthrough” designation, which means the innovations can be fast tracked.

Devices invented at the Institute of Bioelectronic Medicine at Feinstein are used to track neural impulses sent to specific disease targets © Karen Rubin/news-photos-features.com

In the bioengineering lab, he points to the “wireless mouse” – not the computer device, but devices that can be inserted into a mouse to receive signals to stimulate specific nerves, and send the nerve recording back. A mouse is important for research because scientists can create disease in the mouse genetically, locate it, and generate the evidence that can be used to treat humans.

Investing in the Future of Long Island

The $10 million Long Island Investment Fund grant announced today complements historic initiatives and investments for Long Island:

  • $157 million investment — repaving 300 lane miles of state highways to date.
  • More than $457 million for school aid – a 12.7 percent increase compared to FY 2022.
  • $63 million for addiction treatment, recovery and prevention services.
  • The homeowner Tax Rebate Credit, with an average benefit of $1,300 for 494,000 Long Island homeowners.
  • $500 million to develop New York’s offshore wind infrastructure and supply chain – ultimately creating more than 2,000 green jobs.
  • Completing Long Island Rail Road’s historic Third Track project, allowing trains to run more often and creating a smoother ride for LIRR commuters.

____________________

© 2022 News & Photo Features Syndicate, a division of Workstyles, Inc. All rights reserved. For editorial feature and photo information, go to www.news-photos-features.com, email [email protected]. Blogging at www.dailykos.com/blogs/NewsPhotosFeatures. ‘Like’ us on facebook.com/NewsPhotoFeatures, Tweet @KarenBRubin

Nassau County Opens Second COVID-19 Vaccination Site; New York State Expands Eligibility

At the Yes We Can Center in Westbury, which became Nassau County’s second vaccination distribution site, Alex Miller of Port Washington, a special language pathologist, is vaccinated by Dr. Kevin Glassman, a volunteer with Nassau County’s Medical Reserve Corps © Karen Rubin/news-photos-features.com

By Karen Rubin, News-Photos-Features.com

Nassau County, Long Island, opened its second COVID-19 vaccine distribution center, in partnership between the County, Northwell Health and New York State at the “Yes We Can” Community Center in Westbury. The vaccines will be administered by Nassau County Department of Health staff, Members of Nassau County’s Medical Reserve Corps (MRC) with assistance from Northwell Health, which has been designated by New York State as Long Island’s vaccination HUB.  The center began vaccinations on Saturday, January 9 for residents who met the criteria set by New York State. 

Together with Nassau Community College site, Dr. Lawrence Eisenstein, Nassau County Commissioner of Health, anticipates administering up to 1,000 shots a day, depending upon supply of doses.

“Nassau County is leading the way with distribution of the COVID-19 vaccine as we open another vaccine POD,” said Nassau County Executive Curran. “Along with our hospital partners, we have already vaccinated tens of thousands of residents–we are not wasting any time or any doses.

“I am committed to providing equitable access to the vaccine, especially in our hardest hit communities such as the Westbury/New Cassel area,” she said. ”The County will continue to build the infrastructure to dole out this vaccine as quickly and effectively as possible as supply comes in. Thank you to all the volunteers who are the gears keeping our vaccine machine running at full speed.  I encourage all residents who are eligible to roll up their sleeve and get the vaccine.  We can do it, Nassau!”

The site at the “Yes We Can” Community Center in Westbury will be operating 7 days a week to vaccinate eligible residents with an appointment.  The announcement comes less than a week after the first County vaccine center opened at Nassau Community College and inoculated over one thousand people. 

New York State continues to expand the criteria for who can receive the COVID-19 vaccine. For regular updates on who is currently eligible for the vaccine under New York State’s guidance and to make an appointment, residents can visit the County’s vaccine website at www.nassaucountyny.gov/vaccine. Only those who meet the criteria can make an appointment at this time. The vaccine will be provided for free regardless of insurance or immigration status. 

As of Friday, January 8, those who are eligible to be vaccinated are:

  • High-risk hospital staff, affiliates, volunteers and contract staff including State-operated Office of Mental Health (OMH) psychiatric centers
  • Emergency Medical Services (EMS) Personnel
  • Medical Examiners and Coroners
  • Funeral workers who have direct contact with infectious material and bodily fluids.
  • Health care, other high-risk direct care essential staff and agency staff working in Long Term Care Facilities and long-term, congregate settings overseen by Office of People with Developmental Disabilities (OPWDD) the Office of Mental Health (OMH) and the Office of Addiction Services and Supports (OASAS).
  • Residents living in Long Term Care Facilities and in long-term congregate settings overseen by OPWDD, OMH and OASAS
  • FQHC staff
  • Urgent Care providers
  • Any staff administering COVID-19 vaccinations
  • All public facing health care workers including those who provide direct in-person patient care or other staff in a position where they have direct contact with patients.
  • Hospice workers and home health aides
  • Law Enforcement with ALS (advanced lifesaving) certification 

But as of Monday, January 11, the state is expanding the list of those who are eligible to be vaccinated, to Group 1B essential workers including education workers, first responders, public safety workers, public transit workers and people 75 and older.

Nassau County Executive Laura Curran discusses opening a second county COVID-19 vaccination site at the North Hempstead Yes We Can Community Center, in a community that has been disproportionately impacted by the coronavirus. Also on hand: Dr. Lawrence Eisenstein, Nassau County Commissioner of Health; North Hempstead Councilwoman Viviana Russell, Nassau County Legislator Siela A. Bynoe, and State Senator Anna Kaplan © Karen Rubin/news-photos-features.com

“A successful, equitable rollout of the COVID-19 vaccine is the key to ensuring New Yorkers are protected from the coronavirus, and our community is able to reopen and recover from the pandemic era,” said State Senator Anna Kaplan. “It’s critical that every community have access to this life-saving resource, and I’m grateful to County Executive Curran and Governor Cuomo for working together to open a vaccination distribution center at the Yes We Can Center in Westbury. I encourage everyone in our community to roll up their sleeves and get vaccinated as soon as they are able.” 

“Residents of communities like New Cassel and Westbury have played an indispensable role in Nassau County’s pandemic response through their labor as frontline workers, medical professionals and first responders. By establishing this site at the Yes We Can Center, Nassau County and the Town of North Hempstead are recognizing the valiant efforts of these essential workers,” said Nassau County Legislator Siela A. Bynoe.“Most importantly, we are increasing access to the COVID-19 vaccine by embedding this life-saving service in a residential community that has been greatly impacted by the pandemic.”

“The early emergence of COVID-19 vaccines has brought on much needed optimism for the future,” said North Hempstead Supervisor Judi Bosworth.”While availability has been limited, more residents will become eligible to receive the vaccine as distribution centers continue to open and New York’s supply increases. With that said, we are proud to partner with County Executive Curran to make vaccinations available at our facility in Westbury.”

“As a Town we continue to collectively monitor and address the uphill battle of the current pandemic caused by Covid -19 and now the virus’ variant strain of B117. Having access to the newly available Moderna vaccine at a Point of Distribution location set up here at our easily accessible “Yes We Can” Community Center now provides a strong opportunity to keep this deadly virus at bay. As a heavily impacted area, this POD will greatly benefit the community and serve as a strong deterrent against the virus here in New Cassel/Westbury and the surrounding areas,” said North Hempstead Councilwoman Viviana Russell.

Curran said that wide-scale vaccination is key to returning to normalcy, reopening businesses and having kids in school, but until then, and especially with a new, more transmissible strain of the coronavirus now in Long Island, residents must continue to wear masks, keep social distance and wash hands.

How fast a critical mass of people can become vaccinated depends on the supply of the vaccines – so far Pfizer and Moderna are available. It is expected that a third and fourth vaccine, ones that require only a single dose, will also soon be on line.

“We’re putting out doses as fast as we can,” Curran said she said it is likely that by late spring, enough will be available so that anyone who wants a vaccination will be able to get one. I think we will have a relatively normal summer.”

In response to new concerns over the UK strain found in a 64-year old Massapequa man, Dr. Eisenstein said “All viruses mutate. We knew this one would mutate. People should do exactly what they have been doing to protect themselves. We’re not panicked by it. We have the weapon” – the vaccine.

Administering the Moderna vaccination at the Yes We Can Community Center, Westbury, Long Island © Karen Rubin/news-photos-features.com

State Expands Vaccine Distribution Network

On Friday, Governor Cuomo Governor Andrew M. Cuomo today announced the expansion of the state’s vaccination distribution network to help accelerate the administration of the COVID-19 vaccine to New Yorkers currently eligible under group 1A and begin the vaccination of New Yorkers eligible under group 1B. As part of this effort, thousands of new providers and distribution sites are being identified throughout the state. Essential workers and New Yorkers over the age of 75 can begin to make vaccination reservations at administration sites as early as Monday, January 11.

“Over the past week, we have seen hospitals increase their vaccination rates and I thank them for their efforts, but it’s still not enough, so we’re going to accelerate the distribution,” Governor Cuomo said. “We are establishing a network of thousands of providers statewide to both supplement the work of hospitals to vaccinate health care workers, as well as begin the vaccination of other essential workers and individuals 75 and older. The federal government controls the supply, so as we continue to receive more, New York will not only ensure doses are distributed in the most fair and socially equitable way possible, but that health care workers continue to be prioritized so our hospitals remain safe and staffed.”

Currently, 2.1 million New Yorkers in group 1A have been eligible to receive the vaccine. This includes health care and hospital workers, seniors living in nursing homes and assisted-living facilities, and people with disabilities living in congregate settings. Distribution sites were established directly within hospitals to provide direct access to all those eligible. While the speed of vaccinations has increased throughout the past week, further acceleration is still needed.

To further accelerate the vaccination rate of priority health care workers, and begin the vaccination of group 1B essential workers and 75-plus year olds, New York has established a network of additional distribution sites that will supplement the work being done in hospitals to prevent any one hospital from becoming overburdened. The largest group, 3.2 million New Yorkers will be eligible to receive the vaccine in 1B, including:

870,000 Education workers

207,000 first responders

100,000 public safety workers

100,000 public transit workers

1.4 million people 75 and older

This new network will utilize doctors’ offices, Federally-Qualified Health Centers, county health departments, ambulatory centers and pharmacies to get doses in the arms of eligible New Yorkers. More than 1,200 pharmacies have already committed to participating in this network, with nearly 500 scheduled to come on-line next week. Providers across the state will begin accepting vaccination reservations on Monday, January 11 when a centralized state website goes online.

Additionally, the Department of Health is setting up 20 mass distribution sites throughout the state over the next several weeks, with the first of those sites, the Jacob K. Javits Convention Center, slated to open its doors on Wednesday, January 13.

Prioritization

Under this expanded vaccination network, new providers will prioritize their health care workers and hospitals will continue to prioritize unvaccinated members of 1A: health care workers. Additionally, large union groups, including but not limited to police, firefighters and educators, have been asked to organize plans for vaccinating their members to the extent possible. If viable plans are established, these groups will receive weekly allocations from their local health departments. This will enable other providers in the network to focus on New Yorkers over the age of 75, which represents the largest group in 1B at approximately 1.4 million people.

New York is mandating social equity and fair distribution among the groups included in 1B to ensure fair treatment and proportionate allocations both by group and by region. For example, New Yorkers 75 years of age and older represent approximately 45 percent of the population within group 1B and as such, 45 percent of the 1B vaccine supply will be reserved for them. Similarly, 5.9 percent of New York’s 75+ population reside in the Capital District, so 5.9 percent of the allocation for New Yorkers 75+ will be directed to the Capital District. The state will open distribution sites in underserved areas to ensure social equity.

Staffing

To support the increased staffing needs resulting from the establishment of this vaccination network, the Governor has signed an Executive Order to expand the eligible pool of trainees who can administer vaccinations at distribution sites to include:

Licensed Practical Nurses

Pharmacists

Pharmacy Technicians

Midwives

Dentists

Certain Dental Hygienists

Podiatrists

Emergency Medical Technicians

Certain Eligible Students

The expanded vaccination program is welcome at a time when the county and the state are in the midst of a second-wave surge on top of a surge. As of Saturday, January 9, the seven-day positivity rate was 8.7%, 761 were hospitalized, 115 in ICU – the highest number since May – 66 on ventilators and 10 county residents died.

“Tens of thousands of Nassau residents have already received their first vaccine shots with over 1,000 just at the County’s POD (Point of Distribution) at Nassau Community College since Jan 5 alone,” Curran said.

“I have asked that the State increase eligibility and today it was announced that they are expanding beginning on Monday. Every day is crucial, and we must continue to pick up the pace. We’ve concentrated on vaccinating medical and frontline residents as fast as possible so that we can focus on groups like residents over 75, Police, Teachers, Firefighters, Corrections Officers, and more. The County will continue mobilizing its resources at full scale to expedite the vaccine distribution process, and we expect to open another POD tomorrow.

“With vaccine distribution ramping up and cases surging at the same time, my message to residents is simple: Hold fast and stay strong. Help is on the way.”

To make an appointment for a vaccination, go to www.nassaucountyny.gov/vaccine.

Check if you are eligible to receive the vaccine here

Eligible residents can click here to register to be vaccinated at Nassau Community College through New York State’s system.

Eligible residents can click here to register to be vaccinated at the Yes We Can Community Center, 141 Garden Street, Westbury, NY through New York State’s system.

 _________________

© 2021 News & Photo Features Syndicate, a division of Workstyles, Inc. All rights reserved. For editorial feature and photo information, go to www.news-photos-features.com, email [email protected]. Blogging at www.dailykos.com/blogs/NewsPhotosFeatures. ‘Like’ us on facebook.com/NewsPhotoFeatures, Tweet @KarenBRubin

Cuomo Pleads with CDC to Allow Coronavirus Testing in Private Labs to Better Monitor, Contain Spread

Governor Andrew Cuomo tours Northwell Labs with Dr. Dwayne Breining, the Executive Director, Dr. Howard A. Zucker, the state’s Health Commissioner, and Northwell Health’s CEO Michael J. Dowling © Karen Rubin/news-photos-features.com

By Karen Rubin, News-Photos-Features.com

Update: After tour of Northwell Labs, Governor Cuomo announced FDA approval for Northwell to test novel coronavirus: “After days of advocating the FDA and the federal government to expand testing capacity for the novel coronavirus in New York State and working with Northwell and Wadsworth to expedite the process, we just received word that Northwell Laboratories has been authorized to test under Wadsworth’s emergency use authorization. Manual testing of 75 to 80 samples per day will begin at Northwell immediately, but we still need automated testing approved so we can perform thousands per day.

“While this approval is a good first step, the FDA must increase the testing capacity for the State and private labs, because the more tests we run, the more positive people we will find and the better we can control and contain the virus. It’s one thing for the federal government not to have the testing capacity in place themselves – that was bad enough – but there’s no excuse for them not to be authorizing existing labs to do the work.” 

New York State Governor Andrew Cuomo took the Center for Disease Control and federal government to task for failing to authorize private laboratories to test for the coronavirus, and for failing to authorize automated testing which could increase exponentially the number of people tested.

Testing is critical to finding people infected with the coronavirus in order to contain the spread of the infection, he said during a tour of Northwell Health Laboratories on Long Island, where as many as 1000 tests could be done a day using state-of-the-art automated testing devices which can analyze as many as 120 samples at one time.

Northwell’s laboratory is the most sophisticated lab in New York State and one of the most advanced in the nation. But  as yet, CDC  has not authorized private labs to do the tests, and has not authorized the automated testing systems that Northwell has, Cuomo said.

Governor Andrew Cuomo, flanked by Dr. Howard A. Zucker, the state’s Health Commissioner, and Northwell Health’s CEO Michael J. Dowling at Northwell Health Laboratories on Long Island, urged CDC to allow private labs to test for coronavirus using automated systems to better monitor and contain the spread of COVID-19 © Karen Rubin/news-photos-features.com

“CDC has not authorized the use of this lab, which is just outrageous and ludicrous,” the Governor scolded. “CDC, wake up, let the state’s test. Let private labs test. Let’s increase as quickly as possible our testing capacity so we identify the positive people so we can isolate them and we’re successful in our containment.”

The state is “continuing to test people and are working with hospitals and local governments to give them the resources they need to contain the spread of this virus,” Governor Cuomo said. “We mobilized quickly but the federal government has been slow off the mark and they continue to be slow. That’s unacceptable – we need them to approve these private labs today so we can stay ahead of this evolving situation. Worse than the virus right now is the fear pandemic – and getting these additional facilities online will ensure we have more facts that will help keep people calm.”

The Northwell Lab on Long Island would be the first private lab in the state to handle coronavirus testing.

“This is an extraordinary facility,” the Governor said, flanked by his state Health Commissioner Howard A. Zucker, and Northwell Health CEO Michael J. Dowling.

“We are trying to contain spread of virus and to do that, we are testing as many as possible, to  find the positives and isolate them.” If the spread of infection is not contained, he warned, more disastrous measures, such as China and Italy have been forced to undertake – massive quarantines of millions of people – “would be very disruptive to society and the economy.”

Cuomo said that the level of fear surrounding coronavirus (the disease associated with the virus is COVID-19) is unwarranted. “There is more fear, anxiety than facts would justify. This isn’t Ebola, or SARS. This is a virus we have a lot of information on. Johns Hopkins has been tracking 100,000 cases and what happens.”

Most people who become infected will experience mild symptoms like a cold or flu and can recover at home. But for vulnerable populations – the elderly, people who have medical conditions – the disease is dangerous and can be deadly.

The best “weapon” against the disease is to reduce situations that create density.

Cuomo said he is speaking with business leaders across the state to encourage them to offer liberal sick leave so that people who are sick, who feel symptoms, stay home but are still paid; he also is encouraging businesses as well as state and local government offices,  to stagger workers in shifts if possible; and to allow work-at-home where feasible.

Individuals also have a role in keeping themselves safe, he said – wash hands frequently, don’t shake hands, just as in any flu season. He advises people who take mass transit to let a train pass if the cars are too packed, and to move to less crowded cars.  “Reduce density, proximity.”

The single best thing government can do is to test. “The more positives we identify, the more we can isolate to stop the spread.”

The Governor confirmed 16 additional cases of novel coronavirus in New York State since his last update yesterday, bringing the statewide total to 105 confirmed cases on Sunday morning. Of the new cases, 12 are in Westchester County, one in New York City in the Bronx, one in Nassau, one in Suffolk, and one in Ulster.

Of the 105 total individuals in New York State who tested positive for the virus, 82 are in Westchester; 12 are in New York City; five are in Nassau; one in Suffolk; two in Rockland; one in Ulster and two in Saratoga counties.

Cuomo criticized the CDC for being unprepared, even as the outbreak became clear in China by December (“It is delusional not to expect people to come from China”), and only recently allowing states to do their own testing. New York has the Wadsworth lab, but now is asking the CDC to authorize the state to utilize private labs, like Northwell Laboratories.

Technicians at the $60 million Northwell Laboratory on Long Island, the most sophisticated private lab in the state and one of the most advanced in the country. © Karen Rubin/news-photos-features.com

“Not to be using this laboratory, not to be using the other private labs around the state makes no sense whatsoever. Not to be using automated testing, which means rather than a person manually handling a test tube and a test, the machines we saw that handle 120 samples at a time place them in a machine, the machine runs the test. Of course you should be using that technology. And it’s one thing for the CDC not to have the testing capacity in place themselves, but that was bad enough. For the CDC not to be authorizing existing labs to do the work, there’s no excuse for that.” 

Cuomo also criticized the federal government for creating unnecessary confusion, which fuels fear. “The President of the United States says anyone who wants a test can have a test. Vice President of the United States says we don’t have the testing capacity. People say, how can you say both things? You can’t say both things. We don’t have the testing capacity that we need. Not everyone who wants a test can have a test.

“We have to prioritize the people who get the tests to fit our capacity, right. You can’t ask more people to come in and get tested until you know you have the capacity to test them. The number of people coming in for a test must equal the number of tests you can perform. That’s why in New York we have a standard protocol that’s in place all across the state, prioritizing who can get tested to fit our testing capacity. 

A state of the art machine like this at Northwell Labs, Long Island, automates the analysis of 120 test samples at one time, vastly increasing the capacity to test individuals suspected of carrying the coronavirus © Karen Rubin/news-photos-features.com

“Once we increase our testing capacity and we can perform more tests, then we can change the prioritization of those people coming in for the tests. We have a statewide protocol because we don’t want people shopping tests. I don’t want someone from Nassau driving to Suffolk, driving to Manhattan, driving to Westchester because you have different rules on who can get a test. Everyone, everywhere in this state has the same rules, doesn’t matter where you go. Hopefully, the CDC acts responsibly and acts quickly and we raise the capacity, we bring a great facility like this online with the automated testing. We can then get testing per day to about 1000 tests. And then we can calibrate the prioritization to the capacity.”

The $60 million Northwell Laboratory on Long Island, is the most sophisticated private lab in the state and one of the most advanced in the country. © Karen Rubin/news-photos-features.com

 The Governor also addressed price gouging, which is happening across the state and the nation, “symptomatic of fear.”

“It’s unethical, exploitative of fear and illegal,” he said. “To make a few extra bucks on hand sanitizer, they would jeopardize their license to do business. There is an increased penalty for price gouging.” He said that consumers can call a hot line, that state police  are investigating and the state Attorney General has the power to prosecute.

The state’s Division of Consumer Protection has created an online consumer complaint form, where New Yorkers can report suspected price gouging or concerns about improper delivery of quantity. (Consumers who wish to file a complaint can visit https://www.dos.ny.gov/consumerprotection/.)

Also, travel insurance companies and travel agents will offer New York residents and businesses the ability to purchase coverage when making travel plans that would allow them to cancel a trip for any reason, including for reasons related to COVID-19.

The Department of Financial Services issued guidance allowing travel agents and travel insurers to offer this type of coverage after DFS received consumer complaints that such polices were not available in New York State. This new action is designed to provide reassurance to New York businesses and residents who are seeking to make plans that may involve travel to locations that are not currently under travel advisories due to COVID-19.

Six global and national insurance companies have agreed to offer “cancel for any reason” coverage to travelers, including: Allianz, Nationwide, Starr Indemnity, Berkshire, Crum & Forster, and Zurich.

DFS also directed New York State travel insurance issuers to proactively reach out to individuals and businesses who bought their policies to let them know what is covered. (Read a copy of the DFS Insurance Guidance Letter)

Yesterday, the Governor announced that he declared a state of emergency to help New York more quickly and effectively contain the spread of the virus. The state of emergency declaration allows, among other things:

Expedited procurement of cleaning supplies, hand sanitizer and other essential resources

Allowing qualified professionals other than doctors and nurses to conduct testing

Expedited procurement of testing supplies and equipment

Expedited personnel onboarding

Expedited leasing of lab space

Allowing EMS personnel to transport patients to quarantine locations other than just hospitals

Providing clear basis for price gouging and enforcement investigation   

 “We do not want to have to do massive close downs, massive quarantines, and we don’t want members of the vulnerable population getting sick. That is why we are doing what we are doing,” Cuomo said.

“So in sum, CDC let’s move, authorize the State to authorize private labs, get this most sophisticated lab in the State, one of the most sophisticated labs in the country, get this lab to work. Why you wouldn’t makes absolutely no sense.

“And to New Yorkers, we understand the facts. Keep this in perspective. We don’t want a lot of people getting this virus. We don’t want to take more drastic measures. But, if you get the virus, you will get sick, you will recover, you most likely won’t even go to the hospital. And the only the people who we really have to worry about are the vulnerable populations – senior citizens, people with compromised immune systems.

“So keep it all in perspective. I know there’s a whole frenzy about it, the facts do not justify the frenzy, period. The biggest problem we have in this situation is fear, not the virus. The virus we can handle. It’s the fear. And the fear is just unwarranted.”

__________

© 2020 News & Photo Features Syndicate, a division of Workstyles, Inc. All rights reserved. For editorial feature and photo information, go to www.news-photos-features.com, email [email protected]. Blogging at www.dailykos.com/blogs/NewsPhotosFeatures. ‘Like’ us on facebook.com/NewsPhotoFeatures, Tweet @KarenBRubin